Arcus Biosciences, Inc. (RCUS)
22.96
+1.12
(+5.13%)
USD |
NYSE |
Apr 02, 16:00
23.06
+0.10
(+0.44%)
Pre-Market: 05:14
Arcus Biosciences Total Liabilities (Quarterly) : 933.00M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 36.40B |
| Merck & Co., Inc. | 84.20B |
| ACADIA Pharmaceuticals, Inc. | 336.80M |
| Alnylam Pharmaceuticals, Inc. | 4.236B |
| Regeneron Pharmaceuticals, Inc. | 9.302B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.564B |
| Shareholders Equity (Quarterly) | 631.00M |
| Debt to Equity Ratio | 0.3138 |
| Current Ratio | 4.359 |
| Net Debt Paydown Yield | -0.94% |